Search results
Results From The WOW.Com Content Network
On July 8, 2010, Alcon's independent director committee (IDC) had set up a $50 million litigation trust to ensure company's minority shareholders get the best deal from bidder Novartis AG. On April 9, 2019, Alcon completed a 100% spin-off from Novartis. The new standalone company is worth up to 28 billion Swiss francs. In November 2021, Alcon ...
The Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014 ( H.R. 3230; Pub. L. 113–146 (text) (PDF) ), also known as the Veterans Choice Act, is a United States public law that is intended to address the ongoing Veterans Health Administration scandal of 2014. The law expanded the number of options veterans have ...
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
The Veteran Health Identification Card ( VHIC) is an identification card issued by the United States Department of Veterans Affairs (VA) for eligible veterans to receive medical care at VA Medical Facilities. The VHIC protects the privacy of veterans' sensitive information, as it no longer displays the Social Security number or date of birth on ...
Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...
By MATTHEW DALY WASHINGTON (AP) - A bipartisan deal to improve veterans' health care would authorize at least $17 billion to fix the health program scandalized by long patient wait times and ...
The United States Office of the Assistant Secretary for Veterans' Employment and Training (OASVET) was established by Secretary's Order No. 5-81 in December 1981.. The assistant secretary position was created by P.L. 96-466 in October 1980, to replace the Deputy Assistant Secretary for Veterans' Employment position created by P.L. 94-502 in October 1976.
Novartis announces that it will spin-off its ophthalmology division, Alcon, into a separately-traded standalone company in order to focus on its legacy pharmaceuticals business.